International safety notice
Hydroxycarbamide-containing medicinal products – Potential interference with continuous glucose monitoring systems
Ireland / HPRA · IRL · Sep 19, 2024
Key facts
| Title | Hydroxycarbamide-containing medicinal products – Potential interference with continuous glucose monitoring systems |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Hydroxycarbamide-containing medicinal products – Potential interference with continuous glucose monitoring systems |
| Models | 443-51, E89-E90, D-17489 |
| Date | Sep 19, 2024 |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1